The Street Is Finally Waking Up To Phathom Pharmaceuticals Inc (NASDAQ: PHAT)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Earlier, Yahoo Finance discussed this stock as it revealed Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

Phathom Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Phathom Pharmaceuticals Inc is $413.92M. A total of 1.67 million shares were traded on the day, compared to an average of 556.60K shares.

Insider Activity

Additionally, investors take into account insider trades when predicting how a stock will perform. During the recent three months, PHAT has seen 1 BUY and 0 SELL insider trades, representing the acquisition of 2,500 and the disposition of 0 shares. Over the last 12 months, there were 21 BUYs and 7 SELLs from insiders. Insiders purchased 557,919 shares during that period but sold 23,469.

In the most recent transaction, TAKEDA PHARMACEUTICAL CO LTD sold 3,703,703 shares of PHAT for 8.10 per share on Jan 24. After the transaction, the 10% Owner now owns 3,755,583 company shares. In a previous transaction on Jan 19, Henderson Molly sold 6,307 shares at 7.75 per share. PHAT shares that CFO and CBO owns now total 98,698.

Among the insiders who sold shares, Henderson Molly disposed of 2,127 shares on Nov 20 at a per-share price of $7.24. This resulted in the CFO and CBO holding 103,061 shares of PHAT after the transaction. In another insider transaction, Parikh Asit bought 2,500 shares at $7.80 per share on Nov 08. Company shares held by the Director now total 55,000.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. According to analysts who have offered 12-month price targets for PHAT in the last 3 months, the mean price target is $22.71 with high estimates of $28.00 and low estimates of $10.00. In terms of 52-week highs and lows, PHAT has a high of $17.02 and a low of $5.84.

As of this writing, PHAT has an earnings estimate of -$1.08 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.85 per share and a lower estimate of -$1.52. The company reported an EPS of -$0.84 in the last quarter, which was 14.30% higher than expectations of -$0.98.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. PHAT’s latest balance sheet shows that the firm has $183.26M in Cash & Short Term Investments as of fiscal 2021. There were $91.34M in debt and $18.92M in liabilities at the time. Its Book Value Per Share was -$0.31, while its Total Shareholder’s Equity was $72.16M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PHAT is Buy with a score of 4.57.

Most Popular

Related Posts